Chronic cough, defined as a cough persisting for more than eight weeks, is a common reason for medical consultations. Despite its prevalence, the diagnosis and management of this condition can be challenging due to its multifactorial etiology. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
Chronic cough is often associated with common conditions such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). However, it can also be a symptom of more serious underlying conditions like lung cancer or pulmonary fibrosis. Understanding the pathophysiology of chronic cough is crucial for accurate diagnosis and effective treatment.
A systematic diagnostic approach is essential to identify the underlying cause of a chronic cough. This includes a thorough patient history, physical examination, and appropriate investigations such as chest radiographs, spirometry, and when indicated, bronchoscopy. Empirical treatment trials for GERD, asthma, and UACS may also be useful in some cases.
Management of chronic cough should be tailored according to the identified underlying cause. For instance, proton pump inhibitors may be prescribed for GERD-associated cough, while inhaled corticosteroids are often effective for asthma-related cough. Non-pharmacological interventions such as lifestyle modifications and speech therapy can also play a crucial role in managing this condition.
Chronic cough can significantly impact a patient's quality of life, underscoring the importance of a comprehensive approach to its diagnosis and management. A thorough understanding of its etiology, a systematic diagnostic approach, and tailored management strategies are key to improving patient outcomes. Continual research is necessary to further unravel the mystery of chronic cough and enhance our clinical practices.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation